Dr. Reddy’s Laboratories announces the launch of AVIGAN® (Favipiravir) in India
HYDERABAD, INDIA, AUGUST 19, 2020 (GPN)- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of AVIGAN® (Favipiravir) 200 mg Tablets…